13099-35-9 Usage
General Description
17-Bromoheptadecanoic acid is a chemical compound with the molecular formula C17H33BrO2. It is a saturated fatty acid with a bromine atom attached to the carbon chain. 17-BROMOHEPTADECANOIC ACID is often used in the production of surfactants, emulsifiers, and other industrial applications due to its ability to lower the surface tension of liquids. It can also be used in the synthesis of pharmaceuticals and other organic compounds. Additionally, 17-Bromoheptadecanoic acid has been studied for its potential antifungal and antibacterial properties, making it a subject of interest in the field of medical research.
Check Digit Verification of cas no
The CAS Registry Mumber 13099-35-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,0,9 and 9 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 13099-35:
(7*1)+(6*3)+(5*0)+(4*9)+(3*9)+(2*3)+(1*5)=99
99 % 10 = 9
So 13099-35-9 is a valid CAS Registry Number.
InChI:InChI=1/C17H33BrO2/c18-16-14-12-10-8-6-4-2-1-3-5-7-9-11-13-15-17(19)20/h1-16H2,(H,19,20)
13099-35-9Relevant articles and documents
Synthesis and Th1-immunostimulatory activity of α-galactosylceramide analogues bearing a halogen-containing or selenium-containing acyl chain
Hossain, Md. Imran,Hanashima, Shinya,Nomura, Takuto,Lethu, Sébastien,Tsuchikawa, Hiroshi,Murata, Michio,Kusaka, Hiroki,Kita, Shunsuke,Maenaka, Katsumi
, p. 3687 - 3695 (2016/07/20)
A novel series of CD1d ligand α-galactosylceramides (α-GalCers) were synthesized by incorporation of the heavy atoms Br and Se in the acyl chain backbone of α-galactosyl-N-cerotoylphytosphingosine. The synthetic analogues are potent CD1d ligands and stimulate mouse invariant natural killer T (iNKT) cells to selectively enhance Th1 cytokine production. These synthetic analogues would be efficient X-ray crystallographic probes to disclose precise atomic positions of alkyl carbons and lipid–protein interactions in KRN7000/CD1d complexes.